Bukwang Pharmaceutical Co., Ltd.

KOSE:A003000 Stock Report

Market Cap: ₩338.2b

Bukwang Pharmaceutical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Bukwang Pharmaceutical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth38.3%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

May 22
Is Bukwang Pharmaceutical (KRX:003000) Weighed On By Its Debt Load?

Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Apr 03
Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First

Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Mar 08
Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?

Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

Feb 10
Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?

How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Jan 14
How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?

Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Dec 19
Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?

Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

Nov 23
Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bukwang Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSE:A003000 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024116,583-31,55120,51121,740N/A
3/31/2024123,087-28,33619,84421,904N/A
12/31/2023125,928-31,330-11,929-9,362N/A
9/30/2023162,391-19,773-2,7902,761N/A
6/30/2023191,782-4,355-16,682-10,771N/A
3/31/2023191,230-5,259-21,616-16,311N/A
12/31/2022190,909-2,47511,47116,461N/A
9/30/2022183,371-1,326-5,549-3,723N/A
6/30/2022181,5522537,06438,418N/A
3/31/2022182,54817934,63235,469N/A
12/31/2021182,491-91725,73526,525N/A
9/30/2021178,012-4,38016,67317,650N/A
6/30/2021170,537-11,1941,7022,964N/A
3/31/2021168,711-9,47519,53521,223N/A
12/31/2020169,660-7,203-1,231723N/A
9/30/2020171,579140-9,782-8,318N/A
6/30/2020170,9692,817-14,075-13,307N/A
3/31/2020170,116-11,057-34,077-30,982N/A
12/31/2019168,194-7,412-28,313-23,408N/A
9/30/2019158,981-17,457-22,148-15,980N/A
6/30/2019195,507129,926-21,825-14,396N/A
3/31/2019194,863144,874-8,327-3,438N/A
12/31/2018194,224145,6703,0906,817N/A
9/30/2018191,641150,1917,24810,757N/A
6/30/2018153,7319,5013,1447,459N/A
3/31/2018152,1208,878N/A6,331N/A
12/31/2017150,74311,091N/A8,563N/A
9/30/2017144,3068,093N/A-176N/A
6/30/2017140,6754,067N/A2,182N/A
3/31/2017139,5786,664N/A-1,812N/A
12/31/2016138,61815,807N/A-7,763N/A
9/30/2016143,16222,757N/A-6,105N/A
6/30/2016144,39033,640N/A-3,669N/A
3/31/2016141,97533,891N/A1,095N/A
12/31/2015142,13225,139N/A10,298N/A
9/30/2015139,54325,356N/A18,317N/A
6/30/2015139,19721,736N/A20,805N/A
3/31/2015138,95622,783N/A23,255N/A
12/31/2014141,68723,616N/A27,863N/A
9/30/2014139,68122,981N/A32,747N/A
6/30/2014136,85723,001N/A42,009N/A
3/31/2014133,48422,331N/AN/AN/A
12/31/2013130,79519,532N/A36,515N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A003000's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if A003000's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A003000's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A003000's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A003000's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A003000's Return on Equity is forecast to be high in 3 years time


Discover growth companies